Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04278833 · ClinicalTrials.gov registry record · Phase 4
Comparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal Conditions
A Phase 4 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 165
- Enrollment target
NCT04278833: Clinical Trial Phase 4 study, sponsored by Stanford University.
NCT04278833 is a Phase 4 study that was terminated before completion, run by Stanford University. The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04278833, a Phase 4 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 165 participants
- Enrollment target
Study Summary
This aims of this study are: 1. To determine if particulate or non-particulate corticosteroid injections are more effective at treating pain from musculoskeletal pathologies of the hip, glenohumeral joint, biceps tendon, or subacromial/subdeltoid bursa at 2 weeks, 3 months, or 6 months. 2. To determine if there is a significantly different side effect profile between particulate and non-particulate corticosteroids when used for hip, glenohumeral joint, biceps tendon, or subacromial/subdeltoid bursa injections.
Interventions
- DRUG Dexamethasone
- DRUG Triamcinolone or Betamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2021-05-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04278833
The ClinicalTrials.gov registry entry for NCT04278833 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT04278833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04278833 about?
NCT04278833 is a clinical study titled "Comparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal Conditions". This aims of this study are: 1. To determine if particulate or non-particulate corticosteroid injections are more effective at treating pain from musculoskeletal pathologies of the hip, glenohumeral joint, biceps tendon, or subacromial/subdeltoid bursa at 2 weeks, 3 months, or 6 months. 2. To deter...
What is the current status of trial NCT04278833?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 165 participants. The study started on 2020-09-01. Estimated completion is 2021-05-28.
What interventions are being tested in trial NCT04278833?
The interventions under investigation include: Dexamethasone (DRUG), Triamcinolone or Betamethasone (DRUG).
Who is sponsoring clinical trial NCT04278833?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.